BTG (BTG LN)

BTG plc was an international specialist healthcare company that developed and commercialized products targeting critical care, cancer, and other disorders. Its portfolio included interventional medicine products for liver tumors, emphysema, blood clots, and varicose veins, alongside specialty pharmaceuticals. The company was headquartered in London, United Kingdom, and was founded in 1948 as the National Research Development Corporation, later becoming BTG in 1998.